Portfolio company
A-Alpha Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
6 investors
Sectors
About
This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Leash Bio
This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.
AI Proteins
This deep-tech company designs engineered miniprotein biologics for patients and pharmaceutical partners using artificial intelligence and synthetic biology.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
Proteinea
This deep-tech company develops molecular biological medicines for the healthcare industry.
Axiom Therapeutics
This deep-tech company develops covalent medicines for pharmaceutical organisations using an artificial intelligence drug discovery platform.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Abalone Bio
This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.
